Korea may reassess AstraZeneca shot’s age cutoff after second blood clot case
A man in his early 30s came down with a rare blood clot nine days after his first dose of AstraZeneca’s Covid-19 vaccine.
A man in his early 30s came down with a rare blood clot nine days after his first dose of AstraZeneca’s Covid-19 vaccine.
Questions on the origins of the virus centre on whether the virus emerged naturally or was bioengineered, and separately, whether it was leaked from a laboratory - specifically,…